Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM'24

WILMETTE, Ill., June 25, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, toda

GlobeNewswireJun 25 08:00 ET

Monopar Therapeutics(MNPR.US) Officer Buys US$25,573.85 in Common Stock

$Monopar Therapeutics(MNPR.US)$ Officer Cittadine Andrew purchased 32,508 shares of common stock on Jun 18, 20, 2024 at an average price of $0.7867 for a total value of $25,573.85.Source: Announcement

Moomoo NewsJun 21 18:00 ET

Monopar Therapeutics(MNPR.US) Officer Buys US$32,894.4 in Common Stock

$Monopar Therapeutics(MNPR.US)$ Officer Cittadine Andrew purchased 36,000 shares of common stock on Jun 13, 14, 17, 2024 at an average price of $0.9137 for a total value of $32,894.4.Source: Announcem

moomoo NewsJun 17 18:49 ET

Express News | Monopar Therapeutics Inc: Both Companies Will Share Ownership of Filed Patent Application on Use of Pcta as a Linker With Ac-225

ReutersJun 11 07:37 ET

Express News | Monopar Therapeutics: Agreement for Northstar to Provide Co With Powerful Therapeutic Radioisotope Actinium-225 (Ac-225)

ReutersJun 11 07:36 ET

Express News | Monopar Therapeutics: Co and Northstar Got Into Long-Term, Non-Exclusive Master Supply Agreement

ReutersJun 11 07:36 ET